People with Alzheimer’s disease have three to four times more antibodies to two major players in the destructive disease than their healthy counterparts, researchers at the Medical College of Georgia and Veterans Affairs Medical Center in Augusta have found. The ability to measure these specific antibody levels could lead to a method for early diagnosis of the disease – when treatment has the most potential – and even help identify those at risk, say lead researchers Drs. Shyamala Mruthinti and Jerry J. Buccafusco of work currently published online on ScienceDirect and scheduled for publication in the September issue of Neurobiology of Aging.
